Trials / Completed
CompletedNCT00969787
DWP05195 in Healthy Adult Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of orally administrated DWP05195 in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP05195 | tablets, oral administration, single and multiple administrations |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2009-11-01
- First posted
- 2009-09-01
- Last updated
- 2010-04-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00969787. Inclusion in this directory is not an endorsement.